BNP Paribas Financial Markets’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-1,887
| Closed | -$32.5K | – | 3583 |
|
2015
Q4 | $32.5K | Sell |
1,887
-258
| -12% | -$4.44K | ﹤0.01% | 3081 |
|
2015
Q3 | $45.2K | Sell |
2,145
-206
| -9% | -$4.35K | ﹤0.01% | 2933 |
|
2015
Q2 | $116K | Buy |
2,351
+62
| +3% | +$3.07K | ﹤0.01% | 2000 |
|
2015
Q1 | $179K | Buy |
2,289
+1,039
| +83% | +$81.4K | ﹤0.01% | 1586 |
|
2014
Q4 | $75.8K | Sell |
1,250
-5,868
| -82% | -$356K | ﹤0.01% | 1589 |
|
2014
Q3 | $303K | Buy |
7,118
+4,600
| +183% | +$196K | ﹤0.01% | 1452 |
|
2014
Q2 | $156K | Sell |
2,518
-4,852
| -66% | -$300K | ﹤0.01% | 1552 |
|
2014
Q1 | $414K | Buy |
7,370
+7,247
| +5,892% | +$407K | ﹤0.01% | 1335 |
|
2013
Q4 | $6.91K | Sell |
123
-2,461
| -95% | -$138K | ﹤0.01% | 2413 |
|
2013
Q3 | $158K | Sell |
2,584
-822
| -24% | -$50.4K | ﹤0.01% | 1996 |
|
2013
Q2 | $199K | Buy |
+3,406
| New | +$199K | ﹤0.01% | 2011 |
|